If CDC Director Dr. Rochelle Walensky signs off on the decision, children ages 5 through 11 could start receiving COVID vaccines as early as tonight.
The Centers for Disease Control and Prevention’s (CDC) vaccine advisory panel today unanimously recommended Pfizer’s COVID vaccine for children 5 to 11, despite concerns raised during the meeting about Pfizer’s clinical data, the fact that children who previously acquired natural immunity to COVID were included in clinical trials and evidence showing COVID poses little risk to children.
If Dr. Rochelle Walensky, the CDC’s director signs off on the decision, children ages 5 through 11 could start receiving COVID vaccines as early as tonight.
The younger age group will receive one-third of the dose authorized for those 12 and older in two shots at least three weeks apart. The doses will be delivered by smaller needles and stored in smaller vials to avoid a mix-up with adult doses.
The CDC’s guidelines for the vaccine’s use are not legally binding, but heavily influence the medical community’s practice.
Prior to today’s decision by the CDC’s Advisory Committee on Immunization Practices (ACIP) the Biden administration enlisted more than 20,000 pediatricians, family doctors and pharmacies to administer the vaccines — with 15 million doses already packed with dry ice, loaded into small specialized containers and shipped via airplanes and trucks to vaccination sites across the country, federal officials said on Monday.
Read More: CDC Advisors Unanimously Endorse Pfizer’s COVID Vaccine for Kids 5-11 Despite Expert Concerns Over Clinical Data